Maternal Serum Progesterone Levels and Threatened Abortion in Lactating Pregnant Women
Data Collection
Collected from today forward - ProspectiveAbortion, Threatened+1
+ Urogenital Diseases
+ Female Urogenital Diseases and Pregnancy Complications
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: January 1, 2026
Actual date on which the first participant was enrolled.This study focuses on the connection between a hormone called progesterone and the risk of early pregnancy loss in women who become pregnant while breastfeeding. The main goal is to understand the role of progesterone in these pregnancies, specifically looking at its levels during the first trimester and how it might impact the likelihood of experiencing threatened abortion, which is characterized by vaginal bleeding during early pregnancy. In this study, pregnant women who are breastfeeding will have their progesterone levels checked during the first trimester. The presence or absence of threatened abortion will be noted, and various factors such as clinical, obstetric, and demographic data will be recorded. The study aims to provide valuable insights into how progesterone levels might influence the risk of early pregnancy complications in this specific group of women. The findings could potentially improve how we assess risk, diagnose, and manage threatened abortion in women who conceive while breastfeeding.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.150 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria